By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Mentice AB (publ)

Mentice AB (publ) (MNTC.ST)

STO Currency in SEK
kr 14.85
-kr 0.05
-0.34%
Last Update: 17 Jul 2025, 12:27
kr 379.70M
Market Cap
-7.90
P/E Ratio (TTM)
Forward Dividend Yield
kr 13.30 - kr 40.00
52 Week Range

MNTC.ST Stock Price Chart

Explore Mentice AB (publ) interactive price chart. Choose custom timeframes to analyze MNTC.ST price movements and trends.

There is nothing to show.

MNTC.ST Company Profile

Discover essential business fundamentals and corporate details for Mentice AB (publ) (MNTC.ST) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

18 Jun 2019

Employees

131.00

CEO

Frans Venker

Description

Mentice AB (publ) provides endovascular simulation solutions to teaching entities, healthcare systems, and medical device manufacturers. The company operates through Medical Device Industry, Healthcare Systems, and Strategic Alliances segments. It provides software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced and essentials, coronary intermediate, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic artery embolization, radiation safety, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, peripheral angiography, and vascular trauma and cardiac rhythm management, as well as supports interventionalists to transition from transfemoral to transradial access. The company also offers medical simulators for endovascular therapies, and simulator accessories and extensions for endovascular therapies; silicone vasculature for endovascular simulation; cardiac and vascular flow systems; neurovascular flow systems; mentice right heart cath app, a mobile solution for an interactive real-time exploration into the right heart catheterization procedure; mentice live learning center, a remote learning with its VIST G endovascular simulation platform. Its products are used to educate, train, and enhance the practitioners in skills. The company operates in Europe, the Middle East, and Africa; Asia Pacific region; and the Americas. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

MNTC.ST Financial Timeline

Browse a chronological timeline of Mentice AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 May 2026

Upcoming earnings on 11 Feb 2026

Upcoming earnings on 6 Nov 2025

Upcoming earnings on 24 Jul 2025

EPS estimate is -kr 0.14, while revenue estimate is kr 76.75M.

Earnings released on 8 May 2025

EPS came in at -kr 1.08 falling short of the estimated -kr 0.39 by -176.92%, while revenue for the quarter reached kr 54.27M, missing expectations by -40.36%.

Earnings released on 13 Feb 2025

EPS came in at kr 0.08 falling short of the estimated kr 0.22 by -63.64%, while revenue for the quarter reached kr 86.22M, missing expectations by -8.28%.

Earnings released on 7 Nov 2024

EPS came in at -kr 0.51 falling short of the estimated -kr 0.12 by -325.00%, while revenue for the quarter reached kr 57.70M, missing expectations by -40.21%.

Earnings released on 23 Jul 2024

EPS came in at kr 0.67 surpassing the estimated kr 0.04 by +1.78K%, while revenue for the quarter reached kr 100.99M, beating expectations by +29.48%.

Earnings released on 3 May 2024

EPS came in at -kr 0.96 falling short of the estimated kr 0.06 by -1.70K%, while revenue for the quarter reached kr 45.43M, missing expectations by -42.50%.

Earnings released on 15 Feb 2024

EPS came in at -kr 0.11 falling short of the estimated kr 0.18 by -161.11%, while revenue for the quarter reached kr 70.44M, missing expectations by -6.71%.

Earnings released on 26 Oct 2023

EPS came in at kr 0.00 falling short of the estimated kr 0.00 by -14.86%, while revenue for the quarter reached kr 63.90M, beating expectations by +3.06%.

Earnings released on 20 Jul 2023

EPS came in at kr 0.06 falling short of the estimated kr 0.24 by -75.00%, while revenue for the quarter reached kr 74.31M, beating expectations by +19.86%.

Earnings released on 27 Apr 2023

EPS came in at -kr 0.06 surpassing the estimated -kr 0.14 by +57.14%, while revenue for the quarter reached kr 64.97M, beating expectations by +9.18%.

Earnings released on 3 Feb 2023

EPS came in at kr 0.08 falling short of the estimated kr 0.18 by -55.56%, while revenue for the quarter reached kr 68.66M, missing expectations by -5.30%.

Earnings released on 26 Oct 2022

EPS came in at -kr 0.30 falling short of the estimated -kr 0.12 by -150.00%, while revenue for the quarter reached kr 51.10M, missing expectations by -1.73%.

Earnings released on 21 Jul 2022

EPS came in at -kr 0.71 falling short of the estimated -kr 0.20 by -255.00%, while revenue for the quarter reached kr 45.11M, missing expectations by -16.45%.

Earnings released on 27 Apr 2022

EPS came in at -kr 0.30 falling short of the estimated -kr 0.20 by -50.00%, while revenue for the quarter reached kr 53.09M, beating expectations by +10.58%.

Earnings released on 3 Feb 2022

EPS came in at -kr 0.17 falling short of the estimated kr 0.27 by -162.96%, while revenue for the quarter reached kr 67.69M, beating expectations by +9.17%.

Earnings released on 28 Oct 2021

EPS came in at -kr 0.29 falling short of the estimated kr 0.07 by -514.29%, while revenue for the quarter reached kr 38.67M, beating expectations by +314.29%.

Earnings released on 22 Jul 2021

EPS came in at -kr 0.22 matching the estimated -kr 0.22, while revenue for the quarter reached kr 46.39M.

Earnings released on 28 Apr 2021

EPS came in at -kr 0.50 falling short of the estimated -kr 0.21 by -138.10%, while revenue for the quarter reached kr 32.32M.

Earnings released on 4 Feb 2021

EPS came in at kr 0.14 falling short of the estimated kr 0.42 by -66.67%, while revenue for the quarter reached kr 45.94M.

Earnings released on 12 Nov 2020

EPS came in at -kr 0.10 surpassing the estimated -kr 0.12 by +16.67%, while revenue for the quarter reached kr 33.43M.

Earnings released on 13 Aug 2020

EPS came in at -kr 0.46 falling short of the estimated -kr 0.18 by -155.56%, while revenue for the quarter reached kr 24.35M.

MNTC.ST Stock Performance

Access detailed MNTC.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
MNTC.ST
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
MNTC.ST
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More